XML 47 R32.htm IDEA: XBRL DOCUMENT v3.6.0.2
Acquisitions (Tables)
12 Months Ended
Dec. 31, 2016
Business Combinations [Abstract]  
Schedule of Business Acquisition
The following table summarizes the consideration paid for Alveda, the total acquisition related costs incurred by the Company during 2015 in connection with the acquisition, and the fair values of the assets acquired and liabilities assumed (amounts in thousands):

Consideration:
 

Fair value of total consideration transferred
$
35,418

 
 

Acquisition-related costs* :
$
2,256

 
 

Estimated fair value of identifiable assets acquired and liabilities assumed:
 

Accounts receivable
$
911

Inventories
2,673

Prepaid expenses and other current assets
4

Property and equipment
6

Goodwill, deductible
440

Developed Technology
24,858

In-process research and development
3,816

Customer relationships
3,615

Accounts payable and other assumed liabilities
(661
)
Deferred tax liability
(244
)

*At closing, the Company also paid $5.2 million related to Canadian goods and services tax (GST) and the harmonized sales tax (HST), which is not included in the above table as consideration or acquisition related costs, and all amounts have been refunded in 2016.
Finite-Lived and Indefinite-Lived Intangible Assets Acquired
The following sets forth the major categories of the Company’s intangible assets acquired from Alveda and the weighted-average remaining amortization period as of December 31, 2015 for those assets that are not already fully amortized (dollar amounts in thousands):
 
 
 
Gross Carrying
Amount at
12/31/15
 
Accumulated
Amortization at 12/31/15
 
Net Carrying
Amount at
12/31/15
 
Weighted Average
Remaining Amortization
Period
Technology
 
25,243

 
(210
)
 
25,033

 
14.9 years
In-process research and development
("IPR&D")
 
3,875

 

 
3,875

 
N/A - Indefinite lived
Customer relationships
 
3,460

 
(43
)
 
3,417

 
9.9 years
Total
 
32,578

 
(253
)
 
32,325

 
 
Pro Forma Information
The following pro forma information presents the results of operations for the years ended December 31, 2015, and December 31, 2014, as if the Alveda acquisition occurred on January 1, 2014:
           
 
 
 
(amounts in thousands, except for per share amounts)
 
 
For the Years Ended
 
 
December 31, 2015
 
December 31, 2014
Total Revenue
 
$
55,767

 
$
47,284

Net income
 
$
8,443

 
$
6,525

Basic earnings per share
 
$
0.16

 
$
0.13

Diluted earnings (loss) per share
 
$
(0.04
)
 
$
0.11